Cargando…
Association of statin treatment with hepatocellular carcinoma risk in end-stage kidney disease patients with chronic viral hepatitis
Statin use in end-stage kidney disease (ESKD) patients are not encouraged due to low cardioprotective effects. Although the risk of hepatocellular carcinoma (HCC), a frequently occurring cancer in East Asia, is elevated in ESKD patients, the relationship between statins and HCC is not known despite...
Autores principales: | Kim, Hyung Woo, Joo, Young Su, Kang, Shin Chan, Koh, Hee Byung, Han, Seung Hyeok, Yoo, Tae-Hyun, Kang, Shin-Wook, Park, Jung Tak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233705/ https://www.ncbi.nlm.nih.gov/pubmed/35752695 http://dx.doi.org/10.1038/s41598-022-14713-w |
Ejemplares similares
-
Associations among Alzheimer disease, depressive disorder, and risk of end-stage kidney disease in elderly people
por: Kang, Shin Chan, et al.
Publicado: (2022) -
Estimating Average Glucose Levels from Glycated Albumin in Patients with End-Stage Renal Disease
por: Kim, Jwa-Kyung, et al.
Publicado: (2012) -
The Effect of Statin on Epithelial-Mesenchymal Transition in Peritoneal Mesothelial Cells
por: Chang, Tae Ik, et al.
Publicado: (2014) -
Trends in the association between body mass index and blood pressure among 19-year-old men in Korea from 2003 to 2017
por: Koh, Hee Byung, et al.
Publicado: (2022) -
Physical performance and chronic kidney disease development in elderly adults: results from a nationwide cohort study
por: Joo, Young Su, et al.
Publicado: (2020)